Posted by BekkaH on November 27, 2002, at 0:28:34
In reply to Where is the new SNRI Milnacipram?, posted by 3 Beer Effect on November 26, 2002, at 6:05:54
Hi 3 Beers,
Long time, no see! How've you been? How's school? I'm sorry I can't answer your question, but I just read on some other Internet message boards that the FDA just approved Lilly's Atomoxetine, which is a norepinephrine reuptake inhibitor. It will be marketed as an ADD drug under the proprietary name "Strateera." It is not a stimulant and will not be a restricted drug. I read that it is similar to reboxetine, another NRI. I believe Atomoxetine is an antidepressant, but it will not be marketed as such. I think the article said it would be out early in 2003.
Bekka
poster:BekkaH
thread:129362
URL: http://www.dr-bob.org/babble/20021122/msgs/129523.html